Department of Urology, China-Japan Friendship Hospital, Beijing, China.
School of Clinical Medicine, China-Japan Friendship Hospital, Peking University, Beijing, China.
BMJ Open. 2020 Jul 12;10(7):e035943. doi: 10.1136/bmjopen-2019-035943.
To compare the safety and efficacy of balloon and Amplatz for tract dilation in fluoroscopically guided percutaneous nephrolithotomy (PCNL).
EMBASE, PUBMED, MEDLINE and the Cochrane Central Register of Controlled Trials were searched for pertinent studies up until 30 October 2019. Pooled effects were calculated as ORs with 95% CIs or mean differences (MD) with 95% CIs. Endpoints included postoperative decrease in haemoglobin, transfusion rate, complication rate, successful dilation rate, stone-free rate, fluoroscopy time, access time, total operation time and length of postoperative hospitalisation (LPH). Bonferroni's correction was intercalated to reduce the likelihood of making a meta-analytical false positive.
One randomised controlled trial and five controlled clinical trials were included, which involved 1317 patients in total. We found a lower drop in postoperative haemoglobin for patients receiving balloon dilation compared with those in the Amplatz group (MD=-0.21, 95% CI -0.33 to 0.09, p=0.0005; Bonferroni correction a=0.005). Access time in the balloon group was also, on average, 2.61 min shorter than the Amplatz group (MD=-2.61, 95% CI -4.20 to 1.01, p=0.001; Bonferroni correction a=0.005). No significant differences were identified between the two dilation methods in terms of transfusion rate, complication rate, successful dilation rate, stone-free rate, fluoroscopy time, total operation time and LPH.
Balloon dilation is a safe and effective tract dilation technique for access creation during fluoroscopically guided PCNL. Both of methods have similar success rates although balloon dilation is associated with significantly less postoperative haemoglobin decline and shorter access time. Therefore, balloon dilation appears to be the superior tract dilation technique, but further confirmatory research is required to confirm these findings.
比较球囊与 Amplatz 在透视引导经皮肾镜取石术(PCNL)中扩张通道的安全性和疗效。
检索 EMBASE、PUBMED、MEDLINE 和 Cochrane 对照试验中心注册库,检索时间截至 2019 年 10 月 30 日。汇总效应以比值比(OR)和 95%置信区间(CI)或均数差(MD)和 95%CI 表示。终点包括术后血红蛋白下降、输血率、并发症发生率、扩张成功率、结石清除率、透视时间、进入时间、总手术时间和术后住院时间(LPH)。为降低假阳性的可能性,采用 Bonferroni 校正法进行校正。
共纳入 1 项随机对照试验和 5 项对照临床试验,共涉及 1317 例患者。与 Amplatz 组相比,球囊扩张组患者术后血红蛋白下降幅度较低(MD=-0.21,95%CI-0.33 至 0.09,p=0.0005;Bonferroni 校正 a=0.005)。球囊组的进入时间也平均比 Amplatz 组短 2.61 分钟(MD=-2.61,95%CI-4.20 至 1.01,p=0.001;Bonferroni 校正 a=0.005)。两种扩张方法在输血率、并发症发生率、扩张成功率、结石清除率、透视时间、总手术时间和 LPH 方面无显著差异。
球囊扩张是一种安全有效的透视引导 PCNL 通道扩张技术。两种方法的成功率相似,但球囊扩张术后血红蛋白下降幅度明显较小,进入时间较短。因此,球囊扩张似乎是一种更优的通道扩张技术,但需要进一步的证实性研究来证实这些发现。